Shopping Cart 0
Cart Subtotal
AED 0

BioDuro LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

BioDuro LLC (BioDuro), a subsidiary of Pharmaceutical Product Development LLC is a discoverer and developer of small molecule and biologics. The institute offers discovery, development and manufacturing services. Its manufacturing services comprise drug product manufacturing, release and stability testing; clinical storage and distribution; and quality and compliance services. BioDuro offers contract research, pre-formulation, formulation, and analytical development services. The institute provides complete CMC services for small molecule products from pre-formulation through clinical supply. It operates projects in medicinal, synthetic, and computational chemistry. The institute caters to biopharmaceutical and drug development companies. It has its presence in San Diego, Beijing and Shanghai. BioDuro is headquartered in San Diego, California, the US.

BioDuro LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioDuro LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

BioDuro LLC, Medical Devices Deals, 2012 to YTD 2018 9

BioDuro LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioDuro LLC, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

BioDuro Enters into Agreement with Pfizer 11

BioDuro Enters into Agreement with Porton Pharma Solutions 12

BioAtla Enters into Co-Development Agreement with BioDuro 13

Boston Strategics Enters into Agreement with Molecular Response 14

Molecular Response Enters Into Co-Development Agreement With OncoMed Pharma 15

Asset Transactions 16

Crown Bioscience Acquires PDX Business Unit from Molecular Response 16

Acquisition 17

BioDuro Acquires Formex 17

BioDuro LLC-Key Competitors 18

BioDuro LLC-Key Employees 19

BioDuro LLC-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

BioDuro LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioDuro LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

BioDuro LLC, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

BioDuro LLC, Pharmaceuticals & Healthcare, Key Facts 2

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioDuro LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioDuro LLC, Deals By Therapy Area, 2012 to YTD 2018 8

BioDuro LLC, Medical Devices Deals, 2012 to YTD 2018 9

BioDuro LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioDuro Enters into Agreement with Pfizer 11

BioDuro Enters into Agreement with Porton Pharma Solutions 12

BioAtla Enters into Co-Development Agreement with BioDuro 13

Boston Strategics Enters into Agreement with Molecular Response 14

Molecular Response Enters Into Co-Development Agreement With OncoMed Pharma 15

Crown Bioscience Acquires PDX Business Unit from Molecular Response 16

BioDuro Acquires Formex 17

BioDuro LLC, Key Competitors 18

BioDuro LLC, Key Employees 19

BioDuro LLC, Other Locations 20

BioDuro LLC, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

BioDuro LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

BioDuro LLC (BioDuro), a subsidiary of Pharmaceutical Product Development LLC is a discoverer and developer of small molecule and biologics. The institute offers discovery, development and manufacturing services. Its manufacturing services comprise drug product manufacturing, release and stability testing; clinical storage and distribution; and quality and compliance services. BioDuro offers contract research, pre-formulation, formulation, and analytical development services. The institute provides complete CMC services for small molecule products from pre-formulation through clinical supply. It operates projects in medicinal, synthetic, and computational chemistry. The institute caters to biopharmaceutical and drug development companies. It has its presence in San Diego, Beijing and Shanghai. BioDuro is headquartered in San Diego, California, the US.

BioDuro LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioDuro LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

BioDuro LLC, Medical Devices Deals, 2012 to YTD 2018 9

BioDuro LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioDuro LLC, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

BioDuro Enters into Agreement with Pfizer 11

BioDuro Enters into Agreement with Porton Pharma Solutions 12

BioAtla Enters into Co-Development Agreement with BioDuro 13

Boston Strategics Enters into Agreement with Molecular Response 14

Molecular Response Enters Into Co-Development Agreement With OncoMed Pharma 15

Asset Transactions 16

Crown Bioscience Acquires PDX Business Unit from Molecular Response 16

Acquisition 17

BioDuro Acquires Formex 17

BioDuro LLC-Key Competitors 18

BioDuro LLC-Key Employees 19

BioDuro LLC-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

BioDuro LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioDuro LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

BioDuro LLC, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

BioDuro LLC, Pharmaceuticals & Healthcare, Key Facts 2

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioDuro LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioDuro LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioDuro LLC, Deals By Therapy Area, 2012 to YTD 2018 8

BioDuro LLC, Medical Devices Deals, 2012 to YTD 2018 9

BioDuro LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioDuro Enters into Agreement with Pfizer 11

BioDuro Enters into Agreement with Porton Pharma Solutions 12

BioAtla Enters into Co-Development Agreement with BioDuro 13

Boston Strategics Enters into Agreement with Molecular Response 14

Molecular Response Enters Into Co-Development Agreement With OncoMed Pharma 15

Crown Bioscience Acquires PDX Business Unit from Molecular Response 16

BioDuro Acquires Formex 17

BioDuro LLC, Key Competitors 18

BioDuro LLC, Key Employees 19

BioDuro LLC, Other Locations 20

BioDuro LLC, Subsidiaries 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

BioDuro LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.